Results 191 to 200 of about 7,361 (221)
Some of the next articles are maybe not open access.
Current Opinion in Ophthalmology, 2018
Myasthenia gravis is an autoimmune disease that commonly affects the palpebral and extraocular muscles. Ocular myasthenia gravis (OMG) is a variant of the disease that is confined to the ocular muscles but frequently becomes generalized over time.
Elizabeth, Fortin +2 more
openaire +2 more sources
Myasthenia gravis is an autoimmune disease that commonly affects the palpebral and extraocular muscles. Ocular myasthenia gravis (OMG) is a variant of the disease that is confined to the ocular muscles but frequently becomes generalized over time.
Elizabeth, Fortin +2 more
openaire +2 more sources
JAMA, 1982
OCULAR myasthenia is a wellknown, localized form of myasthenia gravis frequently limited to the extraocular muscles. It occurs in 20% to 25% of adult patients with this disorder. 1,2 A patient with ocular myasthenia in whom multiple brief recurrences were each followed by rapid spontaneous remission lasting several years is the subject of this report.
openaire +2 more sources
OCULAR myasthenia is a wellknown, localized form of myasthenia gravis frequently limited to the extraocular muscles. It occurs in 20% to 25% of adult patients with this disorder. 1,2 A patient with ocular myasthenia in whom multiple brief recurrences were each followed by rapid spontaneous remission lasting several years is the subject of this report.
openaire +2 more sources
Klinische Monatsblatter fur Augenheilkunde, 1985
Ocular myasthenia is a special form of general myasthenia gravis characterized by unilateral or bilateral ptosis and eye muscle pareses of distinct variability, depending on the time of day and the state of fatigue of the patient. Most important for diagnosis is the Tensilon test, which can, however, produce negative results.
openaire +1 more source
Ocular myasthenia is a special form of general myasthenia gravis characterized by unilateral or bilateral ptosis and eye muscle pareses of distinct variability, depending on the time of day and the state of fatigue of the patient. Most important for diagnosis is the Tensilon test, which can, however, produce negative results.
openaire +1 more source
Treatment of Ocular Myasthenia With Corticosteroids
Archives of Neurology, 2000O CULAR findings often represent the first, and sometimes the sole manifestation of acquired MG. Ocular MG, with weakness restricted to the ocular muscles, is generally considered a mild subtype of MG. Nonetheless, the diagnosis and management of purely ocular MG may be particularly challenging and frustrating.
openaire +2 more sources
Journal of the National Medical Association, 1994
Ocular dysfunction accounts for nearly 70% of the initial manifestations of myasthenia gravis. Since the prevalence rate of myasthenia gravis is two to 10 cases per 100,000 population, it is important for clinicians to be cognizant of this disorder and its varied ocular presentations.
G A, March, L N, Johnson
openaire +1 more source
Ocular dysfunction accounts for nearly 70% of the initial manifestations of myasthenia gravis. Since the prevalence rate of myasthenia gravis is two to 10 cases per 100,000 population, it is important for clinicians to be cognizant of this disorder and its varied ocular presentations.
G A, March, L N, Johnson
openaire +1 more source
Oftalmologia (Bucharest, Romania : 1990), 2012
The authors present a case of ocular myastenia, suspected by an ophthalmologist and confirmed as diagnosis by a neurologist. There are discussion regarding the latest possibilities of treatment.
Andreea-Madalina, Stefanescu +3 more
openaire +1 more source
The authors present a case of ocular myastenia, suspected by an ophthalmologist and confirmed as diagnosis by a neurologist. There are discussion regarding the latest possibilities of treatment.
Andreea-Madalina, Stefanescu +3 more
openaire +1 more source
[Pediatric myasthenia with ocular involvement].
Journal francais d'ophtalmologieIntroduction : La myasthénie est une maladie rare chez l’enfant avec une incidence estimée de 1 à 5 par million d’enfants. Néanmoins, la gravité potentielle de ses conséquences et l’existence de traitements spécifiques exigent une connaissance de ses modalités de diagnostic.Méthodes : Cette étude rétrospective se base sur l’acquisition de données ...
Prud’homme, L. +5 more
openaire +2 more sources
Preliminary Findings of a Dedicated Ocular Myasthenia Gravis Rating Scale: The OMGRate
Neuro-Ophthalmology, 2020Sui H Wong +2 more
exaly